Trevor Angell

Trevor Angell, MD is an Associate Professor of Clinical Medicine at the Keck School of Medicine of USC. He serves as the Associate Medical Director of the Thyroid Center and is board-certified in Internal Medicine and Diabetes, Endocrinology, and Metabolism.

• Clinical Expertise: Thyroid nodules, thyroid cancer, and thyroid disorders during pregnancy
• Research Focus: Thyroid nodule evaluation, molecular testing, immune checkpoint inhibitor-related thyroid dysfunction

Dr. Angell's research explores the intersection of thyroid pathology, molecular diagnostics, and immune therapy complications. His 15 most recent publications (2025–2022) address topics including:

• Thyroid Cancer: Survival analysis in anaplastic thyroid cancer, surgical extent for medullary thyroid cancer
• Immune Therapy Toxicity: Mechanisms of checkpoint inhibitor diabetes and thyroiditis, JAK inhibitor interventions
• Diagnostic Innovation: Afirma genomic classifiers for medullary and indeterminate nodules
• Population Health: Environmental and social determinants of thyroid function in pregnancy

Dr. Angell has received funding from the American Thyroid Association Research Grant and contributes to editorial boards of Thyroid and the Journal of Clinical Endocrinology and Metabolism. He actively participates in the American Thyroid Association Thyroid Nodule Guidelines Taskforce and the International Thyroid Oncology Group.